Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Popular diabetes drug may pose hidden risk during surgery

NCT ID NCT06420739

First seen Nov 20, 2025 · Last updated May 23, 2026 · Updated 26 times

Summary

This study looks at whether the diabetes drug semaglutide (Ozempic/Wegovy) causes a 'full stomach' in patients who have fasted before elective surgery. A full stomach raises the risk of serious complications during anesthesia. Researchers will use ultrasound to check stomach contents in 100 adults and develop better safety guidelines.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FASTING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Toronto Western Hospital

    Toronto, Ontario, M5T 2S8, Canada

Conditions

Explore the condition pages connected to this study.